Evommune, Inc. SEC filings EVMN
Evommune, Inc. has 138 filings in SEC EDGAR's recent list, going back to Jan 7, 2025. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 15, 2026 | Sep 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 16, 2026 | — |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 144 | Notice of proposed sale | Jun 2, 2026 | — |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 144 | Notice of proposed sale | May 28, 2026 | — |
| 144 | Notice of proposed sale | May 28, 2026 | — |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 19, 2026 | — |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 17, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Nov 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 17, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
Showing 80 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EVMN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2044725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.